ABACAVIR AND LAMIVUDINE
Generic: ABACAVIR AND LAMIVUDINE
Camber PharmaceuticalsManufacturer
ORALRoute
ABACAVIR SULFATEActive Substance
2025-04-16Original Approval
ABACAVIR AND LAMIVUDINE is FDA application ANDA205412, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
EXPOSURE DURING PREGNANCY
23 reports
2
FOETAL EXPOSURE DURING PREGNANCY
19 reports
3
OFF LABEL USE
19 reports
4
HEADACHE
17 reports
5
HYPERSENSITIVITY
16 reports
6
HYPERTENSION
15 reports
7
HEPATIC ENZYME INCREASED
14 reports
8
NAUSEA
14 reports
9
RASH
14 reports
10
PAIN
13 reports